Skip to content

Drug interactions

Irinotecan liposomal + Oxcarbazepine

Severity: Moderate

Irinotecan liposomal and Oxcarbazepine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Oxcarbazepine may lower exposure to irinotecan and its active metabolite SN-38 through CYP3A4 induction. This could reduce antitumor efficacy. Strong inducers are the main concern in labeling, and oxcarbazepine is weaker.

What this interaction means in plain words

Irinotecan liposomal and Oxcarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

CYP3A4 induction diverts irinotecan to inactive oxidative metabolites, reducing SN-38 formation and exposure.

What to do

Prefer a non-enzyme-inducing anticonvulsant where possible, and monitor tumor response and toxicity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan liposomal and Oxcarbazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan liposomal with Oxcarbazepine?

MediHelp rates the interaction as moderate. Irinotecan liposomal and Oxcarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oxcarbazepine may lower exposure to irinotecan and its active metabolite SN-38 through CYP3A4 induction. This could reduce antitumor efficacy. Strong inducers are the main concern in labeling, and oxcarbazepine is weaker.

How serious is the interaction between Irinotecan liposomal and Oxcarbazepine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a non-enzyme-inducing anticonvulsant where possible, and monitor tumor response and toxicity.

What other medicines interact with Oxcarbazepine?

MediHelp also lists interactions of Oxcarbazepine with, for example, Cabotegravir, Rilpivirine, Artemether / lumefantrine. The full list is on the Oxcarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in